Akut mieloid leukémia (AML): vizsgálatok itt: Spanyolország
62 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in SpanyolországDigital Patient-Reported Assessment in Older Adults With Acute Leukemia
- Where
- Oviedo
- Életkor
- 65 év and over
- People
- 20
- Run by
- Fundación para la Investigación Biosanitaria del Principado de Asturias
See details and how to joinNCT07597590 - 2/3. fázisTaking peopleA Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Where
- Badalona, Barcelona, Cáceres, Girona, Granada, L'Hospitalet de Llobregat, Madrid, Málaga, Oviedo, Pamplona, Salamanca, Valencia
- Életkor
- 18 év and over
- People
- 316 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04256317 · EU 2024-515098-93-00 - 2. fázisTaking peopleA Multicenter, Open-Label, Dose-Finding Clinical Trial to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of RVU120 in Combination with Venetoclax in Participants with Acute Myeloid Leukemia Who Failed Prior Therapy with Venetoclax and a Hypomethylating Agent (RIVER-81)
- Where
- Barcelona, Cáceres, Madrid, Málaga, Pamplona, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 191 worldwide
- Run by
- Ryvu Therapeutics S.A.
See details and how to join2023-505911-19-00 - 3. fázisTaking peopleCHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
- Where
- Alicante, Badajoz, Barakaldo, Barcelona, Esplugues De Llobregat, Las Palmas de Gran Canaria, Madrid, Málaga, Murcia, Oviedo, Palma, Santander, Santiago de Compostela, Sevilla, Valencia, Zaragoza
- Életkor
- Up to 64 év
- People
- 675 worldwide
- Run by
- Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-504999-25-00 - 2. fázisTaking peopleSafety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML
- Where
- Barcelona, Cáceres, Madrid, Málaga, Pamplona, Seville, Valencia
- Életkor
- 18 év and over
- People
- 98 worldwide
- Run by
- Ryvu Therapeutics SA
See details and how to joinNCT06191263 - 2. fázisNot yet taking people in SpanyolországRVU120 Rollover Study
- Where
- Pamplona
- Életkor
- 18 év and over
- People
- 14 worldwide
- Run by
- Ryvu Therapeutics SA
See details and how to joinNCT06987058 · EU 2025-521673-14-00 - 2. fázisFut, nem toboroz(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 2. fázisTaking peopleA study to evaluate the safety and efficacy of oral decitabine plus ivosidenib in newly diagnosed adult patients with acute myeloid leukemia older than 60 years and/or inelegible for standard induction chemotherapy
- Where
- Albacete, Alcalá de Henares, Alicante, Burgos, Cáceres, Córdoba, Las Palmas De Gran Canaria, Lugo, Madrid, Málaga, San Cristóbal de La Laguna, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 62 worldwide
- Run by
- Fundacion PETHEMA
See details and how to join2025-523238-17-00 - 1/2. fázisTaking peopleA Study of BGB-11417 in Participants With Myeloid Malignancies
- Where
- Barcelona, Salamanca, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 260 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT04771130 · EU 2023-508881-14-00 - 3. fázisTaking peopleRevumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
- Where
- Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Lleida, Madrid, Palma, Tarragona, Terrassa, Valencia
- Életkor
- 18 év and over
- People
- 448 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT06652438 · EU 2024-512733-32-00 - 1. fázisTaking peopleSafety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Where
- Barcelona, Oviedo, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 171 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06001788 · EU 2023-510288-37-00 - 2/3. fázisTaking peopleL-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
- Where
- Badalona, Madrid, Oviedo, Valencia
- Életkor
- 18 év to 80 év
- People
- 312 worldwide
- Run by
- Moleculin Biotech, Inc.
See details and how to joinNCT06788756 · EU 2024-518359-47-00 - 2. fázisTaking peopleA Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- Where
- Barcelona, Lleida, Logroño, Madrid, Murcia
- Életkor
- 18 év and over
- People
- 332 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04093570 · EU 2024-516293-29-01 - 1. fázisNot yet taking people in SpanyolországA Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Esplugues de Llobregat, Madrid
- Életkor
- Up to 17 év
- People
- 18 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2024-520125-36-00 - 1/2. fázisNot yet taking people in SpanyolországA Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
- Where
- Barcelona, Madrid, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 64 worldwide
- Run by
- Servier
See details and how to joinNCT07719348 · EU 2025-525128-88-00 - 1/2. fázisTaking peopleStudy to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Where
- Badalona, Barcelona, Madrid, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- CellCentric Ltd.
See details and how to joinNCT04068597 - 2. fázisNot yet taking people in SpanyolországA Phase II, Open-Label Randomized Study of Intravenous Tambiciclib in Combination with the Standard of care Venetoclax and Azacitidine in Patients with Newly Diagnosed AML Who Failed to Achieve at Least MLFS After the First Two Cycles of Treatment with Venetoclax and Azacitidine Alone
- Where
- Albacete, Alicante, Valencia
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.
See details and how to join2025-524308-31-00 - 1/2. fázisTaking peoplePhase I/IIa clinical trial with dose escalation to evaluate safety and efficacy of the infusion of CART84 in relapsed/refractory (R/R) acute myeloid leukemia (AML) and acute lymphoblastic T leukemia patients (T-ALL).
- Where
- Barcelona, Valencia
- Életkor
- 18 év and over
- People
- 39
- Run by
- Gyala Therapeutics S.L.
See details and how to join2024-519966-31-00 - 1. fázisTaking peopleStudy to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment
- Where
- Barcelona, Lleida, Logrono, Madrid, Murcia, Valencia
- Életkor
- 18 év and over
- People
- 18 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04953897 · EU 2024-516291-16-00 - 1. fázisTaking peopleStudy to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
- Where
- Barcelona, Lleida, Logrono, Madrid, Murcia, Valencia
- Életkor
- 18 év and over
- People
- 27 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04953910 · EU 2024-516292-33-00 - 3. fázisFut, nem toborozAn Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
- Where
- Badalona, Barcelona, Burgos, Cáceres, Las Palmas de Gran Canaria, Madrid, Terrassa, Valencia
- Életkor
- 18 év and over
- People
- 245 worldwide
- Run by
- Servier Affaires Médicales
See details and how to joinNCT05907057 · EU 2022-501709-11-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Albacete, Barcelona, Cáceres, Las Palmas, Madrid, Oviedo, Salamanca, Santander, Santiago de Compostela, Valencia
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - 1/2. fázisTaking peopleSafety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).
- Where
- Barcelona, Valencia
- Életkor
- 18 év and over
- People
- 33
- Run by
- Gyala Therapeutics
See details and how to joinNCT07471789 - 3. fázisTaking peopleA Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
- Where
- Badalona, Palma
- Életkor
- 18 év and over
- People
- 486 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06389292 · EU 2024-516436-10-00 - 2. fázisTaking peoplePreparation for bone marrow transplant through the combined use of chemo and radiotherapy (intensive or myeloablative: eliminates stem cells)
- Where
- Sevilla
- Életkor
- 18 év and over
- People
- 49
- Run by
- Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla
See details and how to join2024-514484-25-00